Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
USRT vs CSRE: Weighing Broad REIT Exposure Against a Concentrated Active Strategy

USRT vs CSRE: Weighing Broad REIT Exposure Against a Concentrated Active Strategy

Key Takeaways

  • Two paths to U.S. real estate: USRT is a broad, market-cap-weighted index fund, while CSRE is a concentrated, actively managed portfolio of roughly 50 high-conviction real estate holdings.
  • Cost gap is material: CSRE charges a 0.70% net expense ratio versus USRT's 0.08%, a meaningful long-term performance hurdle for the active strategy to overcome.
  • Diversification differs sharply: USRT holds about 127 REITs with its largest position near 9% of assets, while CSRE's top holding, WELL, approaches 15%, concentrating single-stock risk.
  • Structure and track record: USRT launched in 2007 with a deep trading history, while CSRE launched in February 2025 and is non-diversified, giving it a shorter live-performance record.
  • Tickeron AI Verdict: USRT — its lower cost, broader diversification, and established liquidity profile give it the structural edge in this USRT versus CSRE ETF comparison.

Why Compare These Two REIT ETFs

Both CSRE and USRT target the same underlying opportunity — U.S. listed real estate investment trusts (REITs), companies that own and operate income-producing property and pay out most of their taxable income as dividends. Yet they pursue that goal through fundamentally different structures. CSRE is an active, high-conviction fund that concentrates its bets on managers' best ideas, while USRT is a passive, low-cost vehicle spanning the broad U.S. equity REIT market. As interest-rate expectations and sector rotation reshape real estate valuations, comparing these two funds clarifies how cost, diversification, and active selection drive relative positioning for investors seeking the same asset class. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Cohen & Steers Real Estate Active ETF (CSRE) Overview

CSRE is an actively managed ETF sponsored by Cohen & Steers Capital Management. It seeks total return by investing at least 80% of net assets in income-producing common stocks and equity securities issued by real estate companies, primarily REITs and similar entities. The portfolio managers use a bottom-up, relative-value process built on a proprietary valuation model weighing price-to-net asset value (NAV), cash-flow growth, and dividend discount analysis. The fund is non-diversified and holds roughly 49 to 51 positions, with a high degree of concentration: top holdings recently included WELL (around 15%), DLR (~8%), CCI (~6%), EQIX (~5–6%), and PLD (~4%). Its net expense ratio is 0.70%, and its benchmark is the FTSE Nareit All Equity REITs Index. Launched in February 2025, CSRE is a newer entrant with a shorter public track record and turnover that has run in the low-to-mid 50% range.

iShares Core U.S. REIT ETF (USRT) Overview

USRT is a passively managed fund that seeks to track the FTSE Nareit Equity REITs 40 Act Capped Index, a diversified, market-cap-weighted benchmark of U.S.-listed equity REITs that excludes mortgage, infrastructure, and timber REITs. The fund holds approximately 126 to 127 securities and carries a 0.08% net expense ratio, among the lowest in the real estate ETF category. Its top holdings reflect the broad index: WELL (~9%), PLD (~7%), EQIX (~6%), SPG (~4.5%), DLR (~4.3%), PSA (~4%), and O (~4%). Issued by BlackRock and launched in May 2007, USRT offers deep liquidity, a long operational history, and broad sector exposure spanning specialized, healthcare, retail, residential, and industrial REITs.

Industry and Thematic Backdrop

U.S. REITs sit at the intersection of interest rates, credit conditions, and property-specific supply and demand. Both funds are heavily exposed to data-center and tower REITs — including DLR, EQIX, and CCI — that have benefited from sustained demand for digital infrastructure, artificial intelligence computing, and cloud connectivity. Healthcare REITs such as WELL and VTR continue to draw capital from favorable demographic trends. Meanwhile, the broader sector remains sensitive to monetary policy: higher-for-longer borrowing costs pressure property valuations and development returns, while any easing cycle typically supports REIT multiples and capital flows. Sector rotation, earnings cycles among top tenants, and elevated refinancing activity remain key catalysts and risks for both funds. From what I see, this backdrop makes the cost and diversification differences between the two ETFs even more relevant.

Performance and Positioning Comparison

Across recent weeks and months, both CSRE and USRT have moved with the same macro forces — interest-rate expectations and the relative strength of data-center and healthcare property subsectors. Their relative positioning differs more than their broad direction. USRT's wider diversification tempers single-stock volatility and delivers beta-like exposure to the entire equity REIT complex. CSRE's concentration amplifies its exposure to its highest-conviction names, which can enhance returns when those picks outperform but also deepen drawdowns during reversals. Its active tilts toward growth-oriented, digital-infrastructure-heavy REITs and away from some benchmark stalwarts create meaningful tracking divergence from the index. Over recent market cycles, USRT's lower fee and steadier construction have supported competitive net performance, while CSRE's ability to outperform hinges on sustained success in active security selection — a demanding bar given its 0.70% expense ratio versus USRT's 0.08%.

Using Tickeron’s AI Screener for ETF Comparisons

When evaluating ETFs like these, I often turn to Tickeron’s AI Screener to quickly compare holdings, costs, and performance metrics across the sector. It helps streamline the research process and surface relevant peers without manual effort.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: USRT, CSRE

USRT's RSI Indicator ascending out of oversold territory

The RSI Indicator for USRT moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 23 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on USRT as a result. In 71 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for USRT just turned positive on October 09, 2026. Looking at past instances where USRT's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.

USRT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for USRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where USRT advanced for three days, in 261 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

USRT broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for USRT entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are PROLOGIS (NYSE:PLD), Simon Property Group (NYSE:SPG), Tanger (NYSE:SKT), Innovative Industrial Properties (NYSE:IIPR).

Industry description

The investment seeks to track the investment results of the FTSE Nareit Equity REITs 40 Act Capped Index composed of U.S. real estate equities. The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of U.S.-listed equity real estate investment trusts ("REITs"), excluding infrastructure REITs, mortgage REITs, and timber REITs.

Market Cap

The average market capitalization across the iShares Core U.S. REIT ETF (USRT) ETF is 12.42B. The market cap for tickers in the group ranges from 148.14M to 173.78B. WELL holds the highest valuation in this group at 173.78B. The lowest valued company is NLOP at 148.14M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Core U.S. REIT ETF (USRT) ETF was 15%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 6,385%. CUBE experienced the highest price growth at 9%, while MPT experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the iShares Core U.S. REIT ETF (USRT) ETF was 14%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 72
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category RealEstate

Category
Real Estate
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Operating profit rose to £2.0 billion in Q1 2026, up from the prior year period. Basic earnings per share (EPS) increased 15.5% year-over-year to 17.9 pence.
Analysts expect first quarter 2026 EPS of $1.67, a decline from prior year, though recent revisions trend higher. Revenue consensus stands at $9.79 billion, up 12.3% year-over-year, supported by stronger oil prices.